Results Snapshot
Figures in Rs cr
Standalone Annual Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Mar'18
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2024 is 26.76% vs 187.12% in Mar 2023
Standalone Net Profit
YoY Growth in year ended Mar 2024 is 320.41% vs 488.00% in Mar 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2024 is 261.94% vs 85.47% in Mar 2023
Interest
YoY Growth in year ended Mar 2024 is 3.57% vs -3.45% in Mar 2023
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2024 has improved from Mar 2023
Compare Annual Results Of Shukra Pharma. With
Figures in Rs cr
Standalone Annual Results
Change(INR)
Change(%)
Net Sales
74.57
8,558.51
-8,483.94
-99.13%
Other Operating Income
0.00
0.00
0.00
Total Operating income
74.57
8,558.51
-8,483.94
-99.13%
Raw Material Cost
13.38
859.11
-845.73
-98.44%
Purchase of Finished goods
30.41
1,825.86
-1,795.45
-98.33%
(Increase) / Decrease In Stocks
0.70
-60.74
61.44
101.15%
Employee Cost
5.65
1,890.84
-1,885.19
-99.70%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
5.03
1,859.00
-1,853.97
-99.73%
Total Expenditure (Excl Depreciation)
55.17
6,374.07
-6,318.90
-99.13%
Operating Profit (PBDIT) excl Other Income
19.40
2,184.44
-2,165.04
-99.11%
Other Income
2.82
266.64
-263.82
-98.94%
Operating Profit (PBDIT)
22.22
2,451.08
-2,428.86
-99.09%
Interest
0.29
14.57
-14.28
-98.01%
Exceptional Items
0.00
103.53
-103.53
-100.00%
Gross Profit (PBDT)
21.93
2,436.51
-2,414.58
-99.10%
Depreciation
2.05
317.46
-315.41
-99.35%
Profit Before Tax
19.88
2,119.05
-2,099.17
-99.06%
Tax
1.35
399.17
-397.82
-99.66%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
18.54
1,719.88
-1,701.34
-98.92%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
103.53
-103.53
-100.00%
Net Profit
18.54
1,823.41
-1,804.87
-98.98%
Equity Capital
10.95
40.06
-29.11
-72.67%
Face Value
10.00
1.00
0.00
Reserves
46.69
9,583.75
-9,537.06
-99.51%
Earnings per share (EPS)
4.23
45.52
-41.29
-90.71%
Diluted Earnings per share
16.93
45.45
-28.52
-62.75%
Operating Profit Margin (Excl OI)
26.02%
25.52%
0.00
0.50%
Gross Profit Margin
29.41%
28.47%
0.00
0.94%
PAT Margin
24.86%
20.10%
0.00
4.76%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 74.57 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 26.76% vs 187.12% in Mar 2023
Annual - Standalone Net Profit
Standalone Net Profit 18.54 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 320.41% vs 488.00% in Mar 2023
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 19.40 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 261.94% vs 85.47% in Mar 2023
Annual - Interest
Interest 0.29 Cr
in Mar 2024Figures in Rs Cr
YoY Growth in year ended Mar 2024 is 3.57% vs -3.45% in Mar 2023
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.02%
in Mar 2024Figures in Rs %
YoY Growth in year ended Mar 2024 has improved from Mar 2023